Cliical Trials: Close-Out Visits & Archiving

Lessons Learned Meetings After Close-Out to Improve Future Studies Lessons Learned Meetings After Close-Out to Improve Future Studies In the complex world of clinical trials, particularly within the context of a sting agonist clinical trial, there lies an invaluable opportunity for reflection and improvement post-study. This article presents a comprehensive step-by-step tutorial guide on conducting…

Read More “Lessons Learned Meetings After Close-Out to Improve Future Studies” »

Remote Close-Out Models: When and How to Use Them In the rapidly evolving landscape of clinical research, the efficiency and effectiveness of close-out visits are pivotal for the successful completion of clinical trials. As globalization and technological advancements continue to transform the clinical trial ecosystem, remote close-out models have emerged as a practical solution. Particularly…

Read More “Remote Close-Out Models: When and How to Use Them” »

Managing Biobank and Sample Storage Commitments at Study End In the complex landscape of clinical research, managing biobank and sample storage commitments at the study end can be a daunting task for professionals in clinical operations, regulatory affairs, and medical affairs. Effective management is crucial not only for regulatory compliance but also for ensuring that…

Read More “Managing Biobank and Sample Storage Commitments at Study End” »

Close-Out Documentation That Satisfies Auditors and Inspectors Close-Out Documentation That Satisfies Auditors and Inspectors In clinical trials, the close-out phase concludes the research and is critical for ensuring compliance with regulations set by governing bodies such as the FDA, EMA, and MHRA. Proper close-out documentation serves as proof of compliance and is essential for any…

Read More “Close-Out Documentation That Satisfies Auditors and Inspectors” »

Decommissioning Study Systems and Vendor Contracts at Close-Out Effective close-out procedures are a critical phase in the lifecycle of clinical trials. The process of decommissioning study systems and managing vendor contracts at close-out ensures compliance, safeguards data, and prepares the trial for regulatory inspection. This tutorial serves as a step-by-step guide for clinical operations, regulatory…

Read More “Decommissioning Study Systems and Vendor Contracts at Close-Out” »

Transitioning Participants to Standard of Care or New Studies In the realm of clinical research, transitioning participants from clinical trials to standard of care or enrolling them in new studies is a critical process that demands meticulous planning and execution. This article aims to provide clinical operations, regulatory affairs, and medical affairs professionals with a…

Read More “Transitioning Participants to Standard of Care or New Studies” »